Stifel Financial Corp Purchases 14,437 Shares of Laboratory Co. of America Holdings (NYSE:LH)

Stifel Financial Corp grew its position in shares of Laboratory Co. of America Holdings (NYSE:LH - Free Report) by 2.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 608,944 shares of the medical research company's stock after purchasing an additional 14,437 shares during the quarter. Stifel Financial Corp owned approximately 0.73% of Laboratory Co. of America worth $139,643,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. State of Tennessee Department of Treasury lifted its stake in Laboratory Co. of America by 45.4% in the fourth quarter. State of Tennessee Department of Treasury now owns 17,470 shares of the medical research company's stock worth $4,006,000 after purchasing an additional 5,454 shares during the last quarter. TD Waterhouse Canada Inc. increased its holdings in shares of Laboratory Co. of America by 60.2% in the fourth quarter. TD Waterhouse Canada Inc. now owns 950 shares of the medical research company's stock worth $218,000 after buying an additional 357 shares during the period. Tower Research Capital LLC TRC lifted its stake in shares of Laboratory Co. of America by 31.4% in the 4th quarter. Tower Research Capital LLC TRC now owns 4,516 shares of the medical research company's stock valued at $1,036,000 after acquiring an additional 1,080 shares during the last quarter. Thematics Asset Management boosted its holdings in Laboratory Co. of America by 1.8% during the 4th quarter. Thematics Asset Management now owns 25,223 shares of the medical research company's stock valued at $5,784,000 after acquiring an additional 448 shares during the period. Finally, MML Investors Services LLC grew its position in Laboratory Co. of America by 1.3% during the 4th quarter. MML Investors Services LLC now owns 19,428 shares of the medical research company's stock worth $4,455,000 after acquiring an additional 249 shares during the last quarter. 95.94% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Laboratory Co. of America

In related news, CEO Adam H. Schechter sold 6,121 shares of the company's stock in a transaction on Tuesday, February 11th. The shares were sold at an average price of $244.62, for a total value of $1,497,319.02. Following the completion of the transaction, the chief executive officer now owns 86,445 shares of the company's stock, valued at approximately $21,146,175.90. This represents a 6.61 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, COO Mark S. Schroeder sold 5,339 shares of the firm's stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $249.23, for a total value of $1,330,638.97. Following the sale, the chief operating officer now directly owns 4,960 shares in the company, valued at approximately $1,236,180.80. This represents a 51.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 14,258 shares of company stock worth $3,518,177. 0.84% of the stock is owned by company insiders.

Laboratory Co. of America Stock Up 0.0 %

NYSE LH traded up $0.02 during mid-day trading on Friday, reaching $228.60. The stock had a trading volume of 907,300 shares, compared to its average volume of 639,334. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.44 and a quick ratio of 1.30. The stock has a market cap of $19.13 billion, a PE ratio of 25.92, a price-to-earnings-growth ratio of 1.71 and a beta of 0.99. The company has a fifty day moving average price of $235.65 and a 200 day moving average price of $234.90. Laboratory Co. of America Holdings has a 1 year low of $191.97 and a 1 year high of $258.59.

Laboratory Co. of America (NYSE:LH - Get Free Report) last posted its quarterly earnings data on Thursday, February 6th. The medical research company reported $3.45 EPS for the quarter, beating analysts' consensus estimates of $3.40 by $0.05. Laboratory Co. of America had a return on equity of 15.29% and a net margin of 5.73%. On average, research analysts expect that Laboratory Co. of America Holdings will post 16.01 earnings per share for the current year.

Laboratory Co. of America Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 11th. Stockholders of record on Thursday, May 29th will be paid a $0.72 dividend. This represents a $2.88 annualized dividend and a dividend yield of 1.26%. Laboratory Co. of America's dividend payout ratio (DPR) is currently 32.65%.

Analyst Ratings Changes

LH has been the topic of several recent analyst reports. Barclays cut their target price on shares of Laboratory Co. of America from $260.00 to $240.00 and set an "equal weight" rating on the stock in a report on Thursday, April 10th. UBS Group decreased their price objective on shares of Laboratory Co. of America from $293.00 to $286.00 and set a "buy" rating on the stock in a research report on Tuesday, January 28th. Evercore ISI raised shares of Laboratory Co. of America from an "in-line" rating to an "outperform" rating and upped their price objective for the company from $260.00 to $265.00 in a research note on Tuesday, January 7th. Redburn Atlantic initiated coverage on Laboratory Co. of America in a research note on Wednesday, April 2nd. They issued a "buy" rating and a $276.00 target price on the stock. Finally, Citigroup upgraded Laboratory Co. of America from a "neutral" rating to a "buy" rating and lifted their price objective for the stock from $250.00 to $300.00 in a research report on Tuesday, March 4th. Four analysts have rated the stock with a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $268.77.

Laboratory Co. of America Profile

Labcorp Holdings, Inc engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.